FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945774009> ?p ?o ?g. }

• W2945774009 endingPage "2250" @default.
• W2945774009 startingPage "2240" @default.
• W2945774009 abstract "When opportunistic infections occur, patients with inflammatory bowel disease (IBD) commonly display a significantly increased rate of morbidity and mortality. With increasing use of immunosuppressive agents and biological agents, opportunistic infections are becoming a hot topic in the perspective of drug safety in IBD patients. Despite the well-established role of opportunistic infections in the prognosis of IBD patients, there are few epidemiological data investigating the incidence of opportunis-tic infections in IBD patients in China. Besides, the risk factors for opportunistic infection in Chinese IBD patients remain unclear.To predict the incidence of opportunistic infections related to IBD in China, and explore the risk factors for opportunistic infections.A single-center, prospective study of IBD patients was conducted. The patients were followed for up to 12 mo to calculate the incidence of infections. For each infected IBD patient, two non-infected IBD patients were selected as controls. A conditional logistic regression analysis was used to assess associations between putative risk factors and opportunistic infections, which are represented as odds ratios (OR) and 95% confidence intervals (CIs).Seventy (28.11%) out of 249 IBD patients developed opportunistic infections. Clostridium difficile infections and respiratory syncytial virus infections were found in 24 and 16 patients, respectively. In a univariate analysis, factors such as the severity of IBD, use of an immunosuppressant or immunosuppressants, high levels of fecal calprotectin, and C-reactive protein or erythrocyte sedimentation rate were individually related to a significantly increased risk of opportunistic infection. Multivariate analysis indicated that the use of any immunosuppressant yielded an OR of 3.247 (95%CI: 1.128-9.341), whereas the use of any two immunosuppressants yielded an OR of 6.457 (95%CI: 1.726-24.152) for opportunistic infection. Interestingly, when immunosuppressants were used in combination with infliximab (IFX) or 5-aminosalicylic acid, a significantly increased risk of opportunistic infection was also observed. The relative risk of opportunistic infection was greatest in IBD patients with severe disease activity (OR = 9.090; 95%CI: 1.532-53.941, relative to the remission stage). However, the use of IFX alone did not increase the risk of opportunistic infection.Factors such as severe IBD, elevated levels of fecal calprotectin, and the use of immunosuppressive medications, especially when used in combination, are major risk factors for opportunistic infections in IBD patients. The use of IFX alone does not increase the risk of opportunistic infection." @default.
• W2945774009 created "2019-05-29" @default.
• W2945774009 creator A5029686003 @default.
• W2945774009 creator A5031639923 @default.
• W2945774009 creator A5049254579 @default.
• W2945774009 creator A5052215978 @default.
• W2945774009 creator A5084078831 @default.
• W2945774009 date "2019-05-14" @default.
• W2945774009 modified "2023-10-17" @default.
• W2945774009 title "Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease" @default.
• W2945774009 cites W1023016907 @default.
• W2945774009 cites W1535393214 @default.
• W2945774009 cites W1572221909 @default.
• W2945774009 cites W1690259348 @default.
• W2945774009 cites W1730306332 @default.
• W2945774009 cites W1971296953 @default.
• W2945774009 cites W1979184889 @default.
• W2945774009 cites W1984181327 @default.
• W2945774009 cites W2000150379 @default.
• W2945774009 cites W2001337739 @default.
• W2945774009 cites W2020350753 @default.
• W2945774009 cites W2056562550 @default.
• W2945774009 cites W2059127937 @default.
• W2945774009 cites W2069195559 @default.
• W2945774009 cites W2077238491 @default.
• W2945774009 cites W2090978997 @default.
• W2945774009 cites W2095540389 @default.
• W2945774009 cites W2111039376 @default.
• W2945774009 cites W2131632358 @default.
• W2945774009 cites W2132689682 @default.
• W2945774009 cites W2135959117 @default.
• W2945774009 cites W2145436896 @default.
• W2945774009 cites W2146101488 @default.
• W2945774009 cites W2146296806 @default.
• W2945774009 cites W2152751713 @default.
• W2945774009 cites W2171789845 @default.
• W2945774009 cites W2236556070 @default.
• W2945774009 cites W2276190964 @default.
• W2945774009 cites W2326642730 @default.
• W2945774009 cites W2340680662 @default.
• W2945774009 cites W2372967567 @default.
• W2945774009 cites W2396716333 @default.
• W2945774009 cites W2399617849 @default.
• W2945774009 cites W2537379881 @default.
• W2945774009 cites W2605025598 @default.
• W2945774009 cites W2612531277 @default.
• W2945774009 cites W2797152839 @default.
• W2945774009 cites W2894807567 @default.
• W2945774009 cites W2906799977 @default.
• W2945774009 cites W2912763777 @default.
• W2945774009 cites W2914196106 @default.
• W2945774009 cites W2946980189 @default.
• W2945774009 cites W3029397494 @default.
• W2945774009 cites W3149527659 @default.
• W2945774009 cites W4211178974 @default.
• W2945774009 cites W4229808289 @default.
• W2945774009 cites W4293777482 @default.
• W2945774009 doi "https://doi.org/10.3748/wjg.v25.i18.2240" @default.
• W2945774009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6526151" @default.
• W2945774009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31143074" @default.
• W2945774009 hasPublicationYear "2019" @default.
• W2945774009 type Work @default.
• W2945774009 sameAs 2945774009 @default.
• W2945774009 citedByCount "12" @default.
• W2945774009 countsByYear W29457740092019 @default.
• W2945774009 countsByYear W29457740092020 @default.
• W2945774009 countsByYear W29457740092021 @default.
• W2945774009 countsByYear W29457740092022 @default.
• W2945774009 countsByYear W29457740092023 @default.
• W2945774009 crossrefType "journal-article" @default.
• W2945774009 hasAuthorship W2945774009A5029686003 @default.
• W2945774009 hasAuthorship W2945774009A5031639923 @default.
• W2945774009 hasAuthorship W2945774009A5049254579 @default.
• W2945774009 hasAuthorship W2945774009A5052215978 @default.
• W2945774009 hasAuthorship W2945774009A5084078831 @default.
• W2945774009 hasBestOaLocation W29457740091 @default.
• W2945774009 hasConcept C107130276 @default.
• W2945774009 hasConcept C120665830 @default.
• W2945774009 hasConcept C121332964 @default.
• W2945774009 hasConcept C126322002 @default.
• W2945774009 hasConcept C146304588 @default.
• W2945774009 hasConcept C156957248 @default.
• W2945774009 hasConcept C203014093 @default.
• W2945774009 hasConcept C2522874641 @default.
• W2945774009 hasConcept C2778260677 @default.
• W2945774009 hasConcept C2778292693 @default.
• W2945774009 hasConcept C2779134260 @default.
• W2945774009 hasConcept C2779196057 @default.
• W2945774009 hasConcept C2780727368 @default.
• W2945774009 hasConcept C2994496256 @default.
• W2945774009 hasConcept C501593827 @default.
• W2945774009 hasConcept C61511704 @default.
• W2945774009 hasConcept C71924100 @default.
• W2945774009 hasConcept C86803240 @default.
• W2945774009 hasConcept C89423630 @default.
• W2945774009 hasConceptScore W2945774009C107130276 @default.
• W2945774009 hasConceptScore W2945774009C120665830 @default.
• W2945774009 hasConceptScore W2945774009C121332964 @default.

• next